Platelet-Rich Plasma: Are the Obtaining Methods, Classification and Clinical Outcome Always Connected?

References

• MarxRE , CarlsonER , EichstaedtRMet al.Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.85(6), 638–646 (1998).
   PubMed Web of Science ®Google Scholar
• AnituaE. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int. J. Oral Maxillofac. Implants14(4), 529–535 (1999).
   PubMed Web of Science ®Google Scholar
• AnituaE , NurdenP , PradoR , NurdenAT , PadillaS. Autologous fibrin scaffolds: when platelet- and plasma-derived biomolecules meet fibrin. Biomaterials192, 440–460 (2019).
   PubMed Web of Science ®Google Scholar
• MagalonJ , BrandinT , FrancoisPet al.Technical and biological review of authorized medical devices for platelets-rich plasma preparation in the field of regenerative medicine. Platelets32(2), 200–208 (2021).
   PubMed Web of Science ®Google Scholar
• SharunK , PawdeAM. Platelet-rich plasma for hip osteoarthritis: comparing the variables in production protocol and composition. Clin. Rheumatol.39(12), 3899–3901 (2020).
   PubMed Web of Science ®Google Scholar
• AnituaE , PradoR , OriveG. Allogeneic platelet-rich plasma: at the dawn of an off-the-shelf therapy?Trends Biotechnol.35(2), 91–93 (2017).
   PubMed Web of Science ®Google Scholar
• LiH , HicksJJ , WangLet al.Customized platelet-rich plasma with transforming growth factor beta1 neutralization antibody to reduce fibrosis in skeletal muscle. Biomaterials87, 147–156 (2016).
   PubMed Web of Science ®Google Scholar
• KatzJN. Platelet-rich plasma for osteoarthritis and Achilles tendinitis. JAMA326(20), 2012–2014 (2021).
   PubMed Web of Science ®Google Scholar
• DohanEhrenfest DM , RasmussonL , AlbrektssonT. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol.27(3), 158–167 (2009).
   PubMed Web of Science ®Google Scholar
• DeLongJM , RussellRP , MazzoccaAD. Platelet-rich plasma: the PAW classification system. Arthroscopy28(7), 998–1009 (2012).
   PubMed Web of Science ®Google Scholar
• MishraA , HarmonK , WoodallJ , VieiraA. Sports medicine applications of platelet rich plasma. Curr. Pharm. Biotechnol.13(7), 1185–1195 (2012).
   PubMed Web of Science ®Google Scholar
• MautnerK , MalangaGA , SmithJet al.A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PM R7(Suppl.4), S53–S59 (2015).
   PubMedGoogle Scholar
• MagalonJ , ChateauAL , BertrandBet al.DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices. BMJ Open Sport Exerc. Med.2(1), e000060 (2016).
   PubMedGoogle Scholar
• LanaJ , PuritaJ , PaulusCet al.Contributions for classification of platelet rich plasma - proposal of a new classification: MARSPILL. Regen. Med.12(5), 565–574 (2017).
   PubMed Web of Science ®Google Scholar
• HarrisonP. Subcommittee on Platelet P. The use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTH. J. Thromb. Haemost.16(9), 1895–1900 (2018).
   PubMed Web of Science ®Google Scholar
• Acebes-HuertaA , Arias-FernandezT , BernardoAet al.Platelet-derived bio-products: classification update, applications, concerns and new perspectives. Transfus. Apher. Sci.59(1), 102716 (2020).
   PubMed Web of Science ®Google Scholar
• KonE , DiMatteo B , DelgadoDet al.Platelet-rich plasma for the treatment of knee osteoarthritis: an expert opinion and proposal for a novel classification and coding system. Expert Opin. Biol. Ther.20(12), 1447–1460 (2020).
   PubMed Web of Science ®Google Scholar
• AnituaE , PelachoB , PradoRet al.Infiltration of plasma rich in growth factors enhances in vivo angiogenesis and improves reperfusion and tissue remodeling after severe hind limb ischemia. J. Control Release202, 31–39 (2015).
   PubMed Web of Science ®Google Scholar
• AnituaE , PradoR , TroyaMet al.Implementation of a more physiological plasma rich in growth factor (PRGF) protocol: anticoagulant removal and reduction in activator concentration. Platelets27(5), 459–466 (2016).
   PubMed Web of Science ®Google Scholar
• AnituaE , PradoR , OriveG. PRP therapies-is it time for potency assays? Letter to the Editor. Am. J. Sports Med.44(11), NP63–NP64 (2016).
   PubMed Web of Science ®Google Scholar
• AnituaE , PradoR. Addressing reproducibility in stem cell and PRP therapies. Trends Biotechnol.37(4), 340–344 (2019).
   PubMed Web of Science ®Google Scholar
• SarrazinS , LamannaWC , EskoJD. Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol.3(7), a004952 (2011).
   PubMed Web of Science ®Google Scholar
• RogersKW , SchierAF. Morphogen gradients: from generation to interpretation. Annu. Rev. Cell Dev. Biol.27, 377–407 (2011).
   PubMed Web of Science ®Google Scholar
• AnituaE , PradoR , OriveG. Closing regulatory gaps: new ground rules for platelet-rich plasma. Trends Biotechnol.33(9), 492–495 (2015).
   PubMed Web of Science ®Google Scholar
• MagawayCL , MalangaG. Patient registries in orthopedics and orthobiologic procedures: a narrative review. BMC Musculoskelet. Disord.23(1), 543 (2022).
   PubMed Web of Science ®Google Scholar
• MurrayIR , GeeslinAG , GoudieEB , PetriglianoFA , LaPradeRF. Minimum information for studies evaluating biologics in orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells. J. Bone Joint Surg. Am.99(10), 809–819 (2017).
   PubMed Web of Science ®Google Scholar
• SanchezM , JorqueraC , de DicastilloLLet al.Real-world evidence to assess the effectiveness of platelet-rich plasma in the treatment of knee degenerative pathology: a prospective observational study. Ther. Adv. Musculoskelet. Dis.14, 1759720X221100304 (2022).
   PubMed Web of Science ®Google Scholar